These RBPs have a strong relationship with cancer development, e.g., DKC1 is related to the expression of tumor suppressors [31], METTL14 mediates tumor progression through SOX4 alteration and WTAP [32], PABPC4 is downregulated in metastatic cells [33], and MKRN1 modulates tumor progression through the AKT pathway [34]. Here, DKC1 is linked to cancer.